# Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

> **NCT05897034** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 100 (estimated)

## Conditions studied

- Sexually Transmitted Diseases

## Interventions

- **DRUG:** Doxycyclin
- **DRUG:** Pentoxifylline
- **DRUG:** Nitazoxanide 500Mg Oral Tablet

## Key facts

- **NCT ID:** NCT05897034
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-20
- **Primary completion:** 2024-06-20
- **Final completion:** 2028-06-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897034, "Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05897034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*